Search for: "ACTAVIS" Results 701 - 720 of 1,006
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Mar 2013, 5:17 pm by Prashant Reddy
Actavis, Inc:  A Quick Look into Reverse Paymentsby George YuThe name of the game in the pharmaceutical industry is exclusivity. [read post]
25 Mar 2013, 2:10 pm by Lisa Larrimore Ouellette
Actavis today (as I noted in my earlier post previewing the case), which involves when a brand name pharmaceutical company may make a "reverse payment" to a generic company as part of a settlement that delays the generic's market entry. [read post]
13 Mar 2013, 4:45 am by Federal Trade Commission
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
12 Mar 2013, 6:47 am by Sarah Erickson-Muschko
Actavis, scheduled for argument on March 25. [read post]
24 Feb 2013, 9:06 pm by Patent Docs
• Defendants: Actavis LLC; Apotex, Inc.; Apotex Corp.; Bedford Laboratories, Inc.; Dr. [read post]
15 Jan 2013, 11:33 am by Ed Silverman
Companies Agree to Sell Rights to 18 Drugs to Satisfy FTCThe Federal Trade Commission will require Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz International GmbH and Par Pharmaceuticals, Inc, and relinquish the manufacturing and marketing rights to three others, to settle charges that Watson’s proposed $5.9 billion acquisition of Actavis would otherwise be anticompetitive.... [read post]
14 Jan 2013, 6:19 am by Mark Zamora
Although he took only generics, Weeks accused Wyeth, which sold Reglan and is now owned by Pfizer as well as two generic drugmakers – Teva Pharmaceuticals and Actavis – of failing to warn of the risk of long-term use.At issue was whether Weeks could press his lawsuit against Pfizer, a question that a federal court asked the Alabama Supreme Court to decide. [read post]
30 Dec 2012, 9:30 pm by Patent Docs
Actavis Inc. 1:12-cv-01750; filed December 21, 2012 in the District Court of Delaware Infringement of U.S. [read post]
30 Nov 2012, 8:19 am by tracey
(Omega AG) (Omega Ltd.) [2012] EWHC 3440 (Ch) (30 November 2012) Cometson & Anor v Merthyr Tydfil County Borough Council & Anor [2012] EWHC 3446 (Ch) (30 November 2012) High Court (Patents Court) Actavis Group HF v Eli Lilly & Company [2012] EWHC 3316 (Pat) (27 November 2012) High Court (Queen’s Bench Division) Hussain v King Edward VII Hospital [2012] EWHC 3441 (QB) (30 November 2012) O’Dwyer v ITV Plc [2012] EWHC 3321 (QB) (30 November 2012) Harries v Stevenson… [read post]
27 Nov 2012, 8:43 am
To complicate matters further, the first claimant was the Actavis parent company, whereas Actavis’s lawyers had initially written to Lilly’s solicitors stating that they represented a subsidiary, Actavis Group PTC ehf, and its “relevant national subsidiaries”. [read post]
20 Nov 2012, 6:57 am
Richard observes that these comments are made all the more relevant by the recent Kat-rant over the pathetically short time available for consultation in Actavis v Sanofi, a reference to the CJEU in which, this Kat believes, a good case could be made out for a more generous time allowance given the political and economic significance of the case's outcome. [read post]